Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer.
Invest New Drugs. 2015 Apr;33(2):480-9. doi: 10.1007/s10637-014-0189-z. Epub 2014 Nov 29.
Invest New Drugs. 2015.
PMID: 25431127
Free PMC article.
Clinical Trial.
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone.
Graff JN, Beer TM, Alumkal JJ, Slottke RE, Redmond WL, Thomas GV, Thompson RF, Wood MA, Koguchi Y, Chen Y, Latour E, Bergan RC, Drake CG, Moran AE.
Graff JN, et al. Among authors: slottke re.
J Immunother Cancer. 2020 Jul;8(2):e000642. doi: 10.1136/jitc-2020-000642.
J Immunother Cancer. 2020.
PMID: 32616555
Free PMC article.
Clinical Trial.
Item in Clipboard
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer.
Graff JN, Alumkal JJ, Drake CG, Thomas GV, Redmond WL, Farhad M, Cetnar JP, Ey FS, Bergan RC, Slottke R, Beer TM.
Graff JN, et al. Among authors: slottke r.
Oncotarget. 2016 Aug 16;7(33):52810-52817. doi: 10.18632/oncotarget.10547.
Oncotarget. 2016.
PMID: 27429197
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer.
Armstrong AJ, Halabi S, Healy P, Alumkal JJ, Winters C, Kephart J, Bitting RL, Hobbs C, Soleau CF, Beer TM, Slottke R, Mundy K, Yu EY, George DJ.
Armstrong AJ, et al. Among authors: slottke r.
Eur J Cancer. 2017 Aug;81:228-236. doi: 10.1016/j.ejca.2017.02.030. Epub 2017 May 11.
Eur J Cancer. 2017.
PMID: 28502694
Free PMC article.
Clinical Trial.
Item in Clipboard
Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer.
Podolak J, Eilers K, Newby T, Slottke R, Tucker E, Olson SB, Lue HW, Youngren J, Aggarwal R, Small EJ, Graff JN, Alumkal JJ, Beer TM, Thomas GV.
Podolak J, et al. Among authors: slottke r.
Oncotarget. 2017 Mar 13;8(42):71447-71455. doi: 10.18632/oncotarget.16169. eCollection 2017 Sep 22.
Oncotarget. 2017.
PMID: 29069718
Free PMC article.
Item in Clipboard
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab).
Peiffer LB, White JR, Jones CB, Slottke RE, Ernst SE, Moran AE, Graff JN, Sfanos KS.
Peiffer LB, et al. Among authors: slottke re.
Neoplasia. 2022 Oct;32:100822. doi: 10.1016/j.neo.2022.100822. Epub 2022 Jul 28.
Neoplasia. 2022.
PMID: 35908379
Free PMC article.
Item in Clipboard
Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis.
Vartanian K, Slottke R, Johnstone T, Casale A, Planck SR, Choi D, Smith JR, Rosenbaum JT, Harrington CA.
Vartanian K, et al. Among authors: slottke r.
BMC Genomics. 2009 Jan 5;10:2. doi: 10.1186/1471-2164-10-2.
BMC Genomics. 2009.
PMID: 19123946
Free PMC article.
Item in Clipboard
Cite
Cite